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Regarding the cancer diagnosis, the majority of patients have information needs, want to be involved in treatment decisions
and know their prognosis. The difﬁculty for physicians is how to meet individual information needs, give hope, but not deliver
unrealistic expectations. Information that drastically alters the life world of the patient is termed as bad news. Conveying bad
news is a skilled communication, and not at all easy. The amount of truth to be disclosed is subjective. A properly structured
and well-orchestrated communication has a positive therapeutic effect. This is a process of negotiation between patient and
physician, but physicians often ﬁnd it difﬁcult due to many reasons. They feel incompetent and are afraid of unleashing a
negative reaction from the patient or their relatives. The physician is reminded of his or her own vulnerability to terminal
illness, and ﬁnd themselves powerless over emotional distress. Lack of sufﬁcient training in breaking bad news is a handicap
to most physicians and health care workers. Adherence to the principles of client-centered counseling is helpful in attaining
this skill. Fundamental insight of the patient is exploited and the bad news is delivered in a structured manner, because the
patient is the one who knows what is hurting him most and he is the one who knows how to move forward. Six-step SPIKES
protocol is widely used for breaking bad news. In this presentation, we put forward more six-step protocol, the BREAKS protocol
as a systematic and easy communication strategy for breaking bad news. Development of competence in dealing with difﬁcult
situations has positive therapeutic outcome and is a professionally satisfying one.
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Introduction. Sebaceous carcinoma is a rare malignancy derived from adnexal epithelium of sebaceous glands. It usually occurs
in the eyelids, but can occur extraocular (head and neck (75%), followed by the trunk (15%) and extremities (10%)). Diagnosis is
difﬁcult because no typical characteristics and histopathology can resemble squamous cell carcinoma or basal cell carcinoma.
It is an aggressive neoplasm that metastasizes up to 25% of cases and has a high mortality.
Case report. Male 30 years, smoker, painter by profession and allergy to iodinated contrast, presenting Left parietal lesion excised in
2004, with histologically sudoríparo hidradenoma. Relapse and progressive growth presents new performing in MAY/05 excision.
In TAC skull-cervico-thoracic lymph nodes reported bilateral laterocervical <1 cm and occipital Left. Colonoscopy performed
by association with Muir-Torre syndrome, being normal. It manages external RT (60Gy) between August and September/05.
Subsequent checks by our department, physical examination shows no abnormalities. PET-CT was performed in May/10 (due
to iodinated contrast allergy), and inguinal appearing cervical lymphadenopathy malignant metabolic characteristics. Biopsy is
practiced them, not demonstrating malignancy. Year, is performed cervical ultrasound control, suggesting completion of PET-CT
for cervical lymph nodes hypoechoic. This time appear malignant lymph nodes generalized. It was decided to apply analytical
and serology extending them to rule out lymphoma or infectious process. Syphilis serology appears positive. After antibiotic
treatment normalizes PET-CT.
Conclusions. Sebaceous carcinoma is a rare adnexal tumor, presenting distance lymph node metastasis in many cases. The
locoregional radiotherapy after surgery can provide good results. The PET-CT is an excellent diagnostic tool in distant disease,
considering the false positive rate with benign infections or inﬂammations.
http://dx.doi.org/10.1016/j.rpor.2013.03.570
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Oncoproteomics is the study of proteins and their interactions in a cancer cell by proteomic technologies and has the potential to
revolutionize clinical practice, including cancer diagnosis. Recent technological advances in the analysis of the human genome
have opened the door to improving our primitive understanding of the gene expression patterns in cancer. The examination of the
phenotypic and (epi) genetic changes in cutaneous melanoma has identiﬁed several genes deemed central to the development
and progression of melanoma. The role of array-based high-throughput gene expression analysis in understanding the speciﬁc
genes involved as well as the pathways and the comparative gene expression patterns of primary and metastatic melanoma. The
development and clinical application of selective pharmacologic agents are also discussed.We identiﬁed several articles that have
